Literature DB >> 24012885

Angiogenesis, mediated by miR-21, is involved arsenite-induced carcinogenesis.

Yue Zhao1, Yuan Xu, Fei Luo, Wenchao Xu, Bairu Wang, Ying Pang, Jianwei Zhou, Xinru Wang, Qizhan Liu.   

Abstract

Evidence for arsenite-induced lung cancer in humans is strong, but the molecular mechanisms by which arsenite causes cancer remain to be established. Angiogenesis is a fundamental characteristic of cancer and is necessary in its multi-step progression. In this investigation, the mechanism for arsenite-induced angiogenesis was evaluated. Tumors formed from human bronchial epithelial (HBE) cells transformed by arsenite developed new blood vessels, which were prevented by the knockdown of miR-21, and cultures of human umbilical vein endothelial cells (HUVEC) exposed to arsenite developed endothelial tubes, a characteristic of angiogenesis. Also found in transformed HBE cells were up-regulation of a microRNA, miR-21, and increased levels of vascular endothelial growth factor (VEGF), which promotes angiogenesis. Down-regulation of miR-21 in these cells inhibited the arsenite-induced increases of VEGF levels. Thus, we conclude that arsenite induces tumor angiogenesis through processes mediated by miR-21.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Arsenite; Cancer stem cells; Carcinogenesis; miR-21

Mesh:

Substances:

Year:  2013        PMID: 24012885     DOI: 10.1016/j.toxlet.2013.08.020

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  14 in total

Review 1.  miR-21 in ischemia/reperfusion injury: a double-edged sword?

Authors:  Xialian Xu; Alison J Kriegel; Xiaoyan Jiao; Hong Liu; Xiaowen Bai; Jessica Olson; Mingyu Liang; Xiaoqiang Ding
Journal:  Physiol Genomics       Date:  2014-08-26       Impact factor: 3.107

2.  HIF-2α, acting via miR-191, is involved in angiogenesis and metastasis of arsenite-transformed HBE cells.

Authors:  Wenchao Xu; Fei Luo; Baofei Sun; Hua Ye; Jun Li; Le Shi; Yi Liu; Xiaolin Lu; Bairu Wang; Qingling Wang; Qizhan Liu; Aihua Zhang
Journal:  Toxicol Res (Camb)       Date:  2015-11-06       Impact factor: 3.524

3.  Arsenic-exposed Keratinocytes Exhibit Differential microRNAs Expression Profile; Potential Implication of miR-21, miR-200a and miR-141 in Melanoma Pathway.

Authors:  Horacio Gonzalez; Carolina Lema; Robert A Kirken; Rosa A Maldonado; Armando Varela-Ramirez; Renato J Aguilera
Journal:  Clin Cancer Drugs       Date:  2015

Review 4.  The role of microRNAs in metal carcinogen-induced cell malignant transformation and tumorigenesis.

Authors:  Brock Humphries; Zhishan Wang; Chengfeng Yang
Journal:  Food Chem Toxicol       Date:  2016-02-20       Impact factor: 6.023

5.  Interplay of miR-21 and FoxO1 modulates growth of pancreatic ductal adenocarcinoma.

Authors:  Weifeng Song; Lei Wang; Liwei Wang; Qi Li
Journal:  Tumour Biol       Date:  2015-01-27

Review 6.  Interrelationships of circulating tumor cells with metastasis and thrombosis: role of microRNAs.

Authors:  Junli Xue; Victoria K Xie; Peipei Wang; Jiujie Cui; Yong Gao; Zhimin Lu
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

7.  Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy.

Authors:  Kazunari Hirota; Hiroshi Keino; Makoto Inoue; Hitoshi Ishida; Akito Hirakata
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-06-27       Impact factor: 3.117

Review 8.  Dysregulation of microRNAs in metal-induced angiogenesis and carcinogenesis.

Authors:  Lin Wang; Ling-Zhi Liu; Bing-Hua Jiang
Journal:  Semin Cancer Biol       Date:  2021-08-21       Impact factor: 15.707

Review 9.  MiR-21: an environmental driver of malignant melanoma?

Authors:  Bodo C Melnik
Journal:  J Transl Med       Date:  2015-06-27       Impact factor: 5.531

10.  Cardamonin Regulates miR-21 Expression and Suppresses Angiogenesis Induced by Vascular Endothelial Growth Factor.

Authors:  Fu-Sheng Jiang; Sha-Sha Tian; Jin-Jian Lu; Xing-Hong Ding; Chao-Dong Qian; Bin Ding; Zhi-Shan Ding; Bo Jin
Journal:  Biomed Res Int       Date:  2015-07-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.